The most concerning aspect of this is that the myocarditis itself was “focal and mild, as is mostly observed following COVID-19 mRNA vaccination” yet this resulted in a fatal arrhythmia, because cells which are part of the electrical system were affected.
A new study performed on adolescents in Hong Kong who suffered myocarditis after mRNA injection in Circulation appears to be generating quite a lot of discussion over how common it is, and what the long-term outcomes are for those unfortunate enough to suffer from this side effect.
Although there have been several epidemiological analyses of myocarditis, that simple comparison is never made. Where uninjected people are looked at specifically, there is no evidence of an increase in incidence. HART has previously summarised the data after infection in the injected compared to the uninjected.
An alternative approach is to look at how common myocarditis is over time. Did the incidence increase with the arrival of covid in 2020 or the arrival of injections in 2021?
‘Myocarditis is more common after covid than after the vaccine’ is a statement often made in response to safety concerns raised but what is the evidence for these assertions?
Hart recently published an article summarising the results of a study performed in the US military which found that nearly 3% of those vaccinated with smallpox vaccine developed subclinical myocarditis (defined by an increased troponin level – which was prospectively measured in all subjects).
We, the undersigned, are writing to express our deep concern at the guidance regarding further mRNA vaccination after any episode of myocarditis, as detailed in the UKHSA guidance for healthcare professionals.
In 2015 a team of researchers employed by the medical services of the US military published a peer-reviewed paper on the incidence of myocarditis and pericarditis after smallpox vaccination (SPX) and vaccination with an inactivated trivalent influenza vaccine (TIV).
Two new studies on myocarditis / pericarditis after mRNA vaccination have been published in major peer-reviewed journals.
Both are based on very large population samples. Both these studies find significantly higher rates of myocarditis, especially in younger males, than governments have to date acknowledged publicly.
The official narrative claims that vaccines prevent infection and therefore reduce risk of myocarditis from infection. This claim is reliant on two points: 1. Vaccines reducing infections 2. That infection related myocarditis occurs at a lower rate in the vaccinated.
20 August 2021 – The roll out of the COVID-19 vaccine to adolescents has begun, despite evidence that myocarditis is a side effect of the vaccine.
Are medical journals increasingly acting as ‘gatekeepers’ to promote ‘established narratives’ but sideline research that challenges the status quo? Many articles containing ‘controversial’ views that initially achieved publication have been promptly retracted. In the past 5 years, the retraction of papers criticizing the covid vaccines or lockdown policies, for example, has gone stratospheric….
HART publishes two letters from Jonathan Hall to the Press regarding their lack of detailed investigation of the woefull inadequate Vaccine Damage Payment Scheme.
This is a detailed report from the People’s Vaccine Inquiry meeting in London on 4th February, which aimed to highlight omissions and distortions from the official Public Inquiry.
Members of the People’s Vaccine Inquiry held a Press Conference in London at the end of the UK Covid-19 Public Inquiry, Module 4 hearings. The aim was to look at many of the omissions and misinformation of the official Inquiry and give a public voice to the many dissenting health professionals and others who are far from convinced that these products
Furthe updates from the Public Inquiry
HART is grateful to our friends at the UsForThem children’s advocacy group for persisting with a Freedom of Information (FOI) request relating to the decision by the Chief Medical Officers in September 2021 to recommend a certain injectable medical intervention.
Our drug safety monitoring systems are designed to identify an increase in the incidence of a rare condition. That is why they worked relatively well at identifying the Cerebral Venous Sinus Thrombosis and myocarditis cases. They are bad at identifying increases in more common conditions and terrible at identifying multi-system conditions.
A letter to a Professor who has yet to learn the reality of vaccine injury the hard way.
